Irritable Bowel Syndrome Trial, Recruiting NCT05803993 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT05803993
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are able to understand and sign a consent form agreeing to take part in the study
  • You are 18 years old or older
  • You have been diagnosed with irritable bowel syndrome (IBS) where constipation is the main symptom, or where your bowel habits alternate between constipation and diarrhea, based on a specific set of medical guidelines called the Rome IV criteria
  • You have had a colonoscopy (a camera examination of your bowel) within the last 5 years that did not find any bowel disease

Who may not be able to join:

  • You have taken antibiotics or probiotic supplements within the 8 weeks before your first study visit
  • You have been diagnosed with a chronic inflammatory bowel disease (such as Crohn's disease or ulcerative colitis), bowel cancer, celiac disease, or diverticular disease
  • You have serious heart failure or severe heart disease where the heart is pumping at a very low capacity
  • You have severe breathing or respiratory problems
  • You have a serious mental health condition or are considered psychologically unstable by a doctor
  • There is a medical reason why a fecal microbiota transplant (a procedure involving transfer of stool from a healthy donor) or a colonoscopy would be unsafe for you
  • You have previously had surgery on your digestive tract (having had your gallbladder or appendix removed is generally acceptable — confirm with trial site)
  • You have a stoma (an opening on your abdomen connected to your digestive tract)
  • You are currently pregnant or breastfeeding
  • You are already taking part in another clinical trial involving a treatment or intervention
  • You are considered unlikely to reliably follow the study procedures
  • You have any other health condition that the study doctors feel could make it unsafe for you to participate (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 December 2021
Est. completion
23 September 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Improving IBS symptoms assessed with the IBS severity scoring system (IBS-SSS); Number and severity grade of adverse events after FMT

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov